Ramez Sawiris serves as the R&D Head for Haleon Middle East and Africa and is the Vice Chair of MENAP-SMI (Middle East, North Africa, Pakistan Self Medication Industry), where he has played an important role in leading discussions on self-care in the region. With over 20 years of experience in the pharma and consumer healthcare industries, Ramez oversees the research and development activities across the MEA region, ensuring the delivery of innovative and high-quality products that align with consumer needs and local regulatory standards.

Ramez holds a robust background in regulatory affairs, regulatory strategy development, pricing, and external engagement. Through his leadership, Ramez has built and maintained strategic partnerships with key stakeholders including government agencies, industry associations, and healthcare professionals, reinforcing Haleon’s commitment to deliver better everyday health with Humanity across MEA. Ramez also holds an MBA in Management from the University of Bradford, UK and a Bachelor of Pharmacy and pharmaceutical science from Cairo University.

Work Experience:
Haleon
– Head of R&D MEA (July 2022 to Present)
– GlaxoSmithKline Consumer Healthcare

Present
– R&D Senior Director, MEA (2021- July 2022)
– Regulatory Affairs Director -MEA (2014-2021)
– Regulatory Affairs & Quality Director Middle East (2011-2014)
– Regulatory Affairs Director MEPITEL (2003-2008)

Eli Lilly
– Sales, Regulatory and Marketing roles Saudi & Gulf (1994 – 2003)

Education:
– MBA Management (1998-1999) – University of Bradford – United Kingdom
– Bs Ph, Pharmacy (1988-1993) – Cairo University – Egypt